A5079016851- Parasites and Host Interactions
- Vector-borne infectious diseases
- Trypanosoma species research and implications
- Viral Infections and Vectors
- Pneumocystis jirovecii pneumonia detection and treatment
- Dermatological diseases and infestations
- Herpesvirus Infections and Treatments
- Parasitic Infections and Diagnostics
- COVID-19 Clinical Research Studies
- Renal Transplantation Outcomes and Treatments
- COVID-19 Impact on Reproduction
- Congenital Anomalies and Fetal Surgery
- Urological Disorders and Treatments
- Acne and Rosacea Treatments and Effects
- Prenatal Screening and Diagnostics
- Research on Leishmaniasis Studies
- HIV/AIDS drug development and treatment
- Data-Driven Disease Surveillance
- Food Security and Health in Diverse Populations
- Insects and Parasite Interactions
- Drug-Induced Ocular Toxicity
- Transplantation: Methods and Outcomes
- Global Maternal and Child Health
- Parasitic Diseases Research and Treatment
- Reproductive tract infections research
National Center on Birth Defects and Developmental Disabilities
2024
Centers for Disease Control and Prevention
2014-2024
Center for Surveillance, Epidemiology, and Laboratory Services
2021-2022
Center for Global Health
2015-2019
Division of Parasitic Diseases and Malaria
2015-2019
University of Georgia
2016
Kentucky Department for Public Health
2014
Western Kentucky University
2014
The Summary of Notifiable Infectious Diseases and Conditions-United States, 2014 (hereafter referred to as the summary) contains official statistics, in tabular graphic form, for reported occurrence nationally notifiable infectious diseases conditions United States 2014. Unless otherwise noted, data are final totals June 30, 2015. These statistics collected compiled from reports sent by U.S. state territory, New York City, District Columbia health departments National Surveillance System...
Although COVID-19 generally results in milder disease children and adolescents than adults, severe illness from can occur might require hospitalization intensive care unit (ICU) support (1-3). It is not known whether the B.1.617.2 (Delta) variant,* which has been predominant variant of SARS-CoV-2 (the virus that causes COVID-19) United States since late June 2021,† different clinical outcomes compared with variants circulated earlier. To assess trends among adolescents, CDC analyzed new...
Babesiosis is caused by parasites of the genus Babesia, which are transmitted in nature bite an infected tick. can be life threatening, particularly for persons who asplenic, immunocompromised, or elderly.2011-2015.CDC has conducted surveillance babesiosis United States since January 2011, when became a nationally notifiable condition. Health departments states reportable voluntarily notify CDC cases through National Notifiable Diseases Surveillance System (NNDSS) and submit supplemental...
Hydroxychloroquine and chloroquine, primarily used to treat autoimmune diseases prevent malaria, received national attention in early March 2020, as potential treatment prophylaxis for coronavirus disease 2019 (COVID-19) (1). On 20, the Food Drug Administration (FDA) issued an emergency use authorization (EUA) chloroquine phosphate hydroxychloroquine sulfate Strategic National Stockpile be by licensed health care providers patients hospitalized with COVID-19 when determine benefit outweighs...
Infection with Strongyloides stercoralis is typically asymptomatic in immunocompetent hosts, despite chronic infection. In contrast, immunocompromised hosts such as solid organ transplant recipients are at risk for hyperinfection syndrome and/or disseminated disease, frequently resulting fatal outcomes. these may result from reactivation of latent infection or through transmission an infected donor. We describe the Centers Disease Control and Prevention's experience seven clusters...
SUMMARY The 2013 multistate outbreaks contributed to the largest annual number of reported US cases cyclosporiasis since 1997. In this paper we focus on investigations in Texas. We defined an outbreak-associated case as laboratory-confirmed a person with illness onset between 1 June and 31 August 2013, no history international travel previous 14 days. Epidemiological, environmental, traceback were conducted. Of 631 outbreaks, Texas greatest cases, 270 (43%). More than 70 clusters identified...
Abstract Background Heart transplantation has been shown to be a safe and effective intervention for progressive cardiomyopathy from chronic Chagas disease. However, in the presence of immunosuppression required heart transplantation, likelihood disease reactivation is significant. Reactivation may cause myocarditis resulting allograft dysfunction rapid onset congestive failure. rates have well documented Latin America; however, there paucity data regarding risk non‐endemic countries....
Gastroschisis is a serious birth defect with midgut prolapse into the amniotic cavity. The objectives of this study were to evaluate prevalence and time trends gastroschisis among programs in International Clearinghouse for Birth Defects Surveillance Research (ICBDSR), focusing on regional variations maternal age changes population.
We investigated whether Strongyloides infection remains endemic in rural Kentucky's Appalachian regions; 7 of 378 (1.9%) participants tested positive for antibodies. identified no statistically significant association between a test and travel to known country ( P = 0.58), indicating that transmission Kentucky might be ongoing.
Abstract Baylisascaris procyonis roundworms can cause potentially fatal neural larva migrans in many species, including humans. However, the clinical spectrum of baylisascariasis is not completely understood. We tested 347 asymptomatic adult wildlife rehabilitators for B. antibodies; 24 were positive, suggesting that subclinical occurring among this population.
Abstract Background Targeted donor screening for strongyloidiasis performed at the time of organ procurement can prevent this life‐threatening donor‐derived infection. Method The Association Organ Procurement Organizations surveyed members to determine number US organizations ( OPO s) performing Strongyloides infection and their practices. Results All 58 s responded survey. Only 6 (10%) currently screen donors strongyloidiasis; most started 6‐36 months before survey one years prior. used...
Strongyloides stercoralis is an intestinal nematode endemic in the tropics and subtropics. Infection usually acquired through skin contact with contaminated soil, or less commonly, from person to fecal contamination of immediate environment. Infections are often asymptomatic, but can result a pruritic rash, respiratory symptoms (e.g., cough wheeze), gastrointestinal diarrhea vomiting). Immunosuppressed persons develop strongyloides hyperinfection syndrome, which be fatal (1). In June 2015,...
Reports from China describe an increase in the frequency of fetal situs inversus 2023 after country's "zero-Covid" policy was lifted, suggesting association with maternal SARS-CoV-2 infection. However, a report birth defects surveillance data Scandinavia observed no sustained during pandemic (2020-2022 vs. 2018-2019). We examined to assess any U.S. pandemic.
Index Case The index case was a 36 year old US-born male with history of diabetes. He received left kidney and pancreas transplant. Five weeks post-transplant he developed nausea, abdominal pain diarrhea. admitted to the hospital seven post-transplant. Duodenal & skin biopsy showed Strongyloides larvae. treated ivermectin albendazole his immunosuppression decreased. Klebsiella bacteremia both organs were removed due concern for rejection. Pre-transplant serum NEGATIVE antibody.
In June 2016, a physician in northwestern Indiana reported high prevalence of clinically diagnosed Lyme disease among his patients. To further evaluate these findings, the State Department Health and CDC conducted laboratory investigation using specimens from some
Abstract Background In 2018, CDC recommended a highly efficacious adjuvanted recombinant zoster vaccine (RZV, Shingrix) as 2-dose series for prevention of herpes (HZ) immunocompetent persons age ≥50 years, with the 2nd dose 2–6 months after 1st dose. Among Medicare beneficiaries, completion 6 and 12 post initiation was 78% 86%, respectively. Here we estimate proportion adults 50–64 years who completed RZV within or receiving their dose, by using two administrative claims databases. Methods...